Search Bar & Filters
Found 4 Actively Recruiting clinical trials
Actively Recruiting
This research is studying adults who have recurrent calcium-oxalate kidney stones and examines whether oral microbial transplant therapy can alter urine factors linked to these stones. The study focuses on adults with high levels of urine calcium or oxalate and aims to assess changes in these urine substances as well as treatment safety. It is an early phase 1, open-label pilot study without randomization or blinding. Participants are divided into two groups based on their urine test results those with high urine oxalate and those with high urine calcium. All participants first receive an antibiotic treatment with vancomycin and neomycin taken orally twice daily for three days. After a 48 to 72 hour break, they take two capsules of microbial transplant therapy daily for seven days. This treatment is followed by collecting urine and stool samples at various points. Participants are monitored throughout the study with weekly contacts until week 5, followed by telephone or record reviews from months 2 to 6, and further record reviews at months 9 and 12. The primary outcomes include changes in 24-hour urinary oxalate and calcium levels from baseline to weeks 1, 3, and 5, and the frequency of adverse events within 30 days after the microbial transplant therapy. Secondary outcomes track changes in the participants microbiota. The total participation period extends up to one year with multiple assessments.
Actively Recruiting
Researchers are conducting a prospective, observational online study called the Healing ALS Registry Observational Study HAROS involving people diagnosed with Amyotrophic Lateral Sclerosis ALS, Motor Neuron Disease MND, or Primary Lateral Sclerosis PLS. The study aims to verify earlier findings suggesting that these conditions may not always be fatal and could be reversible. It will also evaluate the effects of various therapies and education programs, enrolling at least 1000 participants from the USA and other countries. Participants will enter monthly data into an online registry about their functional status using the ALSFRS-R scale, symptoms, dietary intake, supplements, medications, and therapies, including integrative medicine approaches like acupuncture and meditation. Education about treatment options is available online but optional. Participants choose their own treatment plans and may participate in other studies while recording all relevant information in the registry. Throughout the study, participants will update their information monthly for at least one year and up to ten years. Researchers will assess outcomes annually using various tools such as the ALS Functional Rating Scale - Revised, supplementary questionnaires, and mindset scores. They will also track changes in weight, blood markers, and urine toxins to analyze treatment effectiveness and disease progression over time.
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.
Actively Recruiting
This research aims to evaluate the use of the PIVO device, a needle-free blood draw tool, for collecting blood cultures in emergency department patients. The study focuses on reducing the number of needle sticks while ensuring accurate detection of potential bloodstream infections. The research is observational and will assess the devices usage and blood culture contamination rates in several emergency departments within a large healthcare system. The study will start at three main emergency departments with over 100,000 annual visits combined and may expand to three more sites depending on initial findings. Staff will receive structured training on how to use the PIVO device, including workflow and documentation procedures. Blood cultures will be collected using PIVO in different scenarios aligned with FDA approval, and standard blood draw methods will also be used for comparison. Data collection will last 13 months with periodic interim analyses and a survey of clinical staff comfort and recommendations about the device. Participants will be patients having blood cultures drawn in the emergency department. Researchers will gather data from electronic health records, device logs, and manual culture reviews. They will measure PIVO use rates, contamination rates of blood cultures, and staff satisfaction with the device. Interim analyses will guide ongoing use at study sites, and final results will be prepared after full data review. The study covers a full year of data collection following staff training and includes surveys to assess usability and workflow impact.